Neurozyme
Natural health product licensed in Canada
- Licence holder
- New Chapter Inc
- NPN or DIN-HM
- 80003250
- Status
- Inactive licence
- Licence date
- 23 April 2007
- Revision date
- Not provided
- Form
- Gélule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Centella asiatica Potency : 10 % asiaticoside | 60 mg | Not calculated |
| Centella asiatica Potency : 10 % triterpenes | Not specified | Not calculated |
| Zingiber officinale Potency : 30 % pungent compounds | 15 mg | Not calculated |
| Zingiber officinale Potency : 8 % Zingiberene | Not specified | Not calculated |
| Zingiber officinale Potency : 3 % Pungent compounds | Not specified | Not calculated |
| Ocimum sanctum Potency : 2 % ursolic acid | 10 mg | Not calculated |
Non-medicinal ingredients
Apis mellifera, Carob, Maltodextrine, Eau purifiée, huile d'olive, Glycérine végétale, Silicon dioxide colloïdal, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | Not specified |
Uses authorised in Canada
Promotes mental Clarity. Supports normal cerebrovascular health. Chemical solvent-free botanical extracts.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are breastfeeding, pregnant, or considering pregnancy, you should consult you health care practitioner prior to using this product. Discontinue if hypersensitivity occurs. Consult a health care practitioner prior to use if you have impaired liver function, or if you are taking diabetic, anti-psychotic and/or blood-thinning medication. May cause drowsiness. Extra caution is advised in driving or operating heavy machinery. For prolonged use, consult a healthcare practitioner.
Source
Official Health Canada record, licence 80003250
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.